Mounjaro (tirzepatide), Eli Lilly’s Type 2 diabetes drug, helped obese and overweight adults lose an average of 64 pounds after 84 weeks in a phase 3 trial.
Read the full post on Becker's Hospital Review - Healthcare News
Mounjaro helps patients lose 60+ pounds in study
